# Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).

Study · id `cardio:ct-nct01586910` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01586910](<https://clinicaltrials.gov/study/NCT01586910>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01586910

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 1746 participants.

## Technical summary

Registry record NCT01586910. Randomized; no masking; primary purpose treatment. Start 2012-04 (actual); primary completion 2018-07 (actual). Results posted on 2019-09-17.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1746 participants (enrolled count; ClinicalTrials.gov record NCT01586910, source copy `cardio:ctgov-nct01586910-2026-06-24`, retrieved 2026-10-26)
- Started: 2012-04 (actual) (ClinicalTrials.gov record NCT01586910, source copy `cardio:ctgov-nct01586910-2026-06-24`, retrieved 2026-10-26)
- Primary completion: 2018-07 (actual) (ClinicalTrials.gov record NCT01586910, source copy `cardio:ctgov-nct01586910-2026-06-24`, retrieved 2026-10-26)
- Completion: 2026-11 (anticipated) (ClinicalTrials.gov record NCT01586910, source copy `cardio:ctgov-nct01586910-2026-06-24`, retrieved 2026-10-26)
- Results first posted: 2019-09-17 (ClinicalTrials.gov record NCT01586910, source copy `cardio:ctgov-nct01586910-2026-06-24`, retrieved 2026-10-26)
- Countries: United States; Canada; Denmark; Germany; Netherlands; Spain; Sweden; Switzerland; United Kingdom (ClinicalTrials.gov record NCT01586910, source copy `cardio:ctgov-nct01586910-2026-06-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01586910-2026-06-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
- Acronym: SURTAVI
- Condition: Severe Aortic Stenosis
- Intervention (Device): Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
- Intervention (Procedure): Surgical Aortic Valve Replacement (SAVR)
- Intervention (Device): Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)
- Lead sponsor: Medtronic Cardiovascular
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Medtronic (`cardio:medtronic`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Neurological Complications After Transcatheter Versus Surgical Aortic Valve Replacement in Intermediate-Risk Patients (`cardio:pubmed-30360820`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Comparison of Outcomes After Transcatheter vs Surgical Aortic Valve Replacement Among Patients at Intermediate Operative Risk With a History of Coronary Artery Bypass Graft Surgery: A Post Hoc Analysis of the SURTAVI Randomized Clinical Trial (`cardio:pubmed-31215985`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Clinical outcomes of TAVI or SAVR in men and women with aortic stenosis at intermediate operative risk: a post hoc analysis of the randomised SURTAVI trial (`cardio:pubmed-32715995`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: The Impact of Transfusions on Mortality After Transcatheter or Surgical Aortic Valve Replacement (`cardio:pubmed-33217396`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients (`cardio:pubmed-38658126`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 3e2d29f411d9caf9c0e940f324b9ff09727707b886088222ce88bcd096cac852
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
